Evidence map›Paper›PMID 35821860›Full record

ReviewFrontiers in aging2022

The Role of Microbiota in

Aranzazu Arias-Rojas, Igor Iatsenko

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in aging, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
10.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it, 53 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. The Gut Microbiota ofMicroorganisms · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Infection and immunity · 2025
    Review
  10. Article
  11. Article
  12. Article
  13. Alzheimer's disease and gut-brain axis:Frontiers in neuroscience · 2025
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Master regulators of biological systems in higher dimensions.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  20. Resistance to host antimicrobial peptides mediates resilience of gut commensals during infection and aging inProceedings of the National Academy of Sciences of the United States of America · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Aranzazu Arias-RojasMax Planck Institute for Infection Biology, Berlin, Germany.
Igor IatsenkoMax Planck Institute for Infection Biology, Berlin, Germany.
Max Planck Institute for Infection Biology · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Intestinal microbial communities participate in essential aspects of host biology, including nutrient acquisition, development, immunity, and metabolism. During host aging, dramatic shifts occur in the composition, abundance, and function of the gut microbiota. Although such changes in the microbiota are conserved across species, most studies remain descriptive and at most suggest a correlation between age-related pathology and particular microbes. Therefore, the causal role of the microbiota in host aging has remained a challenging question, in part due to the complexity of the mammalian intestinal microbiota, most of which is not cultivable or genetically amenable. Here, we summarize recent studies in the fruit fly

Indexed as

agingdrosophiladysbiosisdysplasiaintestinal immunitylifespanmicrobiota

Identifiers

PMID35821860
PMCPMC9261426
OpenAlexW4280635691

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.